论文部分内容阅读
64例发热期入院的流行性出血热病人,随机分为两组,每组32人.对照组采用综合治疗措施,治疗组除综合治疗措施外,加用654-2(40mg/日,静滴).治疗结果表明,少尿期越期率治疗组高于对照组(p<0.05);尿蛋白消失时间及血小板恢复正常时间治疗组少于对照组;治疗组全部治愈,对照组病死率为9.4%.说明654-2治疗流行性出血热有疗效.
Sixty-four patients with epidemic hemorrhagic fever who were admitted to hospital during the fever period were randomly divided into two groups with 32 patients in each group.All the patients in the control group were treated with the combination of 654-2 (40mg / d) ) Treatment results showed that oliguria period over the treatment group was higher than the control group (p <0.05); urinary protein disappearance of time and platelet recovery time in the treatment group less than the control group; the treatment group were cured, the control group mortality was 9.4% Description 654-2 for the treatment of epidemic hemorrhagic fever curative.